6 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... COVID-19 Specific Medications ... #criticalcare # ... NonIntensivist #diagnosis ... #management
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
- Differential Diagnosis ... Failure, Toxins/Medications ... #Differential #Diagnosis ... #criticalcare # ... algorithm #treatment #management
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
Awakening Trial (SAT ... scenario / sedation indication ... non-OTC prolonging agent ... #CriticalCare # ... diagnosis #management
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
common in OR; in MICU ... Vasopressors #Inotropes #management ... #criticalcare # ... summary #comparison ... #pharmacology #indications
Hepatorenal Syndrome - Diagnosis and Management Summary
Who gets HRS?
 • Decompensated cirrhosis
 • Typically with existing
Hepatorenal Syndrome - Diagnosis ... and Management ... Summary Who gets ... a precipitant: Medications ... Typically requires ICU
Indications for Implantable Cardioverter-Defibrillator (ICD) in Patients with Ischemic Heart Disease (IHD) to Prevent Sudden Cardiac
Indications for ... Cardioverter-Defibrillator (ICD ... guideline-directed management ... defibrillator #indications ... #cardiology #diagnosis